Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study

被引：0
|
作者：
Han Eol Jeong
Sohee Park
Yunha Noh
Sungho Bea
Kristian B. Filion
Oriana H. Y. Yu
Seung Hun Jang
Young Min Cho
Dong Keon Yon
Ju-Young Shin
机构：
[1] Sungkyunkwan University,School of Pharmacy
[2] Sungkyunkwan University,Department of Biohealth Regulatory Science
[3] Biostatistics,Departments of Medicine and of Epidemiology
[4] and Occupational Health,Centre for Clinical Epidemiology
[5] McGill University,Division of Endocrinology and Metabolism
[6] Lady Davis Institute,Division of Pulmonary, Allergy, and Critical Care Medicine, College of Medicine
[7] Jewish General Hospital,Department of Internal Medicine
[8] Jewish General Hospital,Department of Translational Medicine
[9] McGill University,Department of Internal Medicine
[10] Hallym University Sacred Heart Hospital,Institute On Aging
[11] Hallym University,Department of Pediatrics
[12] Seoul National University College of Medicine,Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology (SAIHST)
[13] Seoul National University College of Medicine,undefined
[14] Seoul National University Hospital,undefined
[15] Seoul National University,undefined
[16] Medical Science Research Institute,undefined
[17] Kyung Hee University College of Medicine,undefined
[18] Kyung Hee University Medical Center,undefined
[19] Kyung Hee University College of Medicine,undefined
[20] Sungkyunkwan University,undefined
来源：
BMC Medicine | / 21卷
关键词：
Sodium-glucose cotransporter 2 inhibitors; Respiratory effectiveness; Type 2 diabetes; Population-based cohort;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study
    Jeong, Han Eol
    Park, Sohee
    Noh, Yunha
    Bea, Sungho
    Filion, Kristian B.
    Yu, Oriana H. Y.
    Jang, Seung Hun
    Cho, Young Min
    Yon, Dong Keon
    Shin, Ju-Young
    BMC MEDICINE, 2023, 21 (01)
  • [2] Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study
    Kim, Min
    Ha, Kyoung Hwa
    Lee, Junyoung
    Park, Sangshin
    Oh, Kyeong Seok
    Bae, Dae-Hwan
    Lee, Ju Hee
    Kim, Sang Min
    Choi, Woong Gil
    Hwang, Kyung-Kuk
    Kim, Dong-Woon
    Cho, Myeong-Chan
    Kim, Dae Jung
    Bae, Jang-Whan
    KOREAN CIRCULATION JOURNAL, 2024, 54 (05) : 256 - 267
  • [3] Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Yu, Oriana H. Y.
    Chang, Yoosoo
    Cho, Juhee
    Sinn, Dong Hyun
    Cho, Young Min
    Shin, Ju-Young
    GUT, 2023, 72 (05) : 1020 - 1022
  • [4] Atherothrombotic Outcomes After Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase-4 Inhibitors in Patients With Type 2 Diabetes: A Territory-Wide Retrospective Cohort Study
    Ng, Pauline Yeung
    Ng, Andrew Kei-Yan
    Ip, April
    Sin, Wai Ching
    Yiu, Kai-Hang
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (01):
  • [5] Sodium-glucose Cotransporter-2 Inhibitors as Modulator of Dipeptidyl Peptidase-4 in Diabetes
    Rafeeq, Misbahuddin M.
    Haque, Shahnaz
    Sain, Ziaullah M.
    Alzamami, Ahmad
    Alturki, Norah A.
    Mashraqi, Mutaib M.
    Alghamdi, Youssef Saeed
    Alniwaider, Rashed Ahmed
    Patel, Ayyub
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2021, 55 (04) : 1008 - 1016
  • [6] Sodium glucose cotransporter 2 inhibitors and the risk of respiratory outcomes among patients with type 2 diabetes: A nationwide cohort study
    Jeong, Han Eol
    Park, Sohee
    Noh, Yunha
    Filion, Kristian
    Yu, Oriana Hoi Yun
    Jang, Seung Hun
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 333 - 334
  • [7] Risk of hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: A nationwide cohort study
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Chang, Yoosoo
    Sinn, Dong Hyun
    Yu, Oriana Hoi Yun
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 7 - 8
  • [8] Effects of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Glucose Linked coTransporter-2 Inhibitors on cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis
    Savarese, Gianluigi
    D'Amore, Carmen
    Federici, Massimo
    De Martino, Fabiana
    Dellegrottaglie, Santo
    Marciano, Caterina
    Ferrazzano, Francesca
    Losco, Teresa
    Lund, Lars H.
    Trimarco, Bruno
    Rosano, Giuseppe M. C.
    Perrone-Filardi, Pasquale
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 595 - 601
  • [9] Effect of Add-On Therapy of Sodium-Glucose Cotransporter 2 Inhibitors and Dipeptidyl Peptidase 4 Inhibitors on Adipokines in Type 2 Diabetes Mellitus
    Shaheer, Abid
    Kumar, Ashok
    Menon, Palat
    Jallo, Mahir
    Basha, Shaikh
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2021, 13 (06): : 355 - 362
  • [10] Sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase IV inhibitors and risk of dementia among patients with type 2 diabetes and comorbid mental disorders: A population-based cohort study
    Hong, Bin
    Lee, Hyesung
    Choi, Ahhyung
    Kim, Woo Jung
    Cho, Young Min
    Yon, Dong Keon
    Shin, Ju-Young
    DIABETES & METABOLISM, 2024, 50 (06)
12345